STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Company

Nautilus Biotechnology, Inc.

Filed

June 17, 2022

Period of Report

June 15, 2022

Accession Number

0001062993-22-015188